Inflammation during obesity is not all bad: evidence from animal and human studies
- PMID: 23269411
- PMCID: PMC3774179
- DOI: 10.1152/ajpendo.00266.2012
Inflammation during obesity is not all bad: evidence from animal and human studies
Abstract
Chronic inflammation is a characteristic of obesity and is associated with accompanying insulin resistance, a hallmark of type 2 diabetes mellitus (T2DM). Although proinflammatory cytokines are known for their detrimental effects on adipose tissue function and insulin sensitivity, their beneficial effects in the regulation of metabolism have not drawn sufficient attention. In obesity, inflammation is initiated by a local hypoxia to augment angiogenesis and improve adipose tissue blood supply. A growing body of evidence suggests that macrophages and proinflammatory cytokines are essential for adipose remodeling and adipocyte differentiation. Phenotypes of multiple lines of transgenic mice consistently suggest that proinflammatory cytokines increase energy expenditure and act to prevent obesity. Removal of proinflammatory cytokines by gene knockout decreases energy expenditure and induces adult-onset obesity. In contrast, elevation of proinflammatory cytokines augments energy expenditure and decreases the risk for obesity. Anti-inflammatory therapies have been tested in more than a dozen clinical trials to improve insulin sensitivity and glucose homeostasis in patients with T2DM, and the results are not encouraging. One possible explanation is that anti-inflammatory therapies also attenuate the beneficial effects of inflammation in stimulating energy expenditure, which may have limited the efficacy of the treatment by promoting energy accumulation. Thus, the positive effects of proinflammatory events should be considered in evaluating the impact of inflammation in obesity and type 2 diabetes.
Figures


Similar articles
-
The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.PLoS One. 2015 Aug 26;10(8):e0136304. doi: 10.1371/journal.pone.0136304. eCollection 2015. PLoS One. 2015. PMID: 26308623 Free PMC article.
-
Fight against fibrosis in adipose tissue remodeling.Am J Physiol Endocrinol Metab. 2021 Jul 1;321(1):E169-E175. doi: 10.1152/ajpendo.00558.2020. Epub 2021 May 31. Am J Physiol Endocrinol Metab. 2021. PMID: 34056922 Free PMC article. Review.
-
Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.Eur J Pharmacol. 2020 Aug 15;881:173204. doi: 10.1016/j.ejphar.2020.173204. Epub 2020 May 19. Eur J Pharmacol. 2020. PMID: 32439261
-
Regulation of energy balance by inflammation: common theme in physiology and pathology.Rev Endocr Metab Disord. 2015 Mar;16(1):47-54. doi: 10.1007/s11154-014-9306-8. Rev Endocr Metab Disord. 2015. PMID: 25526866 Free PMC article. Review.
-
Adipose tissue vascularization: its role in chronic inflammation.Curr Diab Rep. 2011 Jun;11(3):203-10. doi: 10.1007/s11892-011-0183-1. Curr Diab Rep. 2011. PMID: 21327583 Free PMC article. Review.
Cited by
-
Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice.Int J Mol Sci. 2014 Jun 27;15(7):11473-94. doi: 10.3390/ijms150711473. Int J Mol Sci. 2014. PMID: 24979131 Free PMC article.
-
Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice.PLoS One. 2014 Apr 16;9(4):e95399. doi: 10.1371/journal.pone.0095399. eCollection 2014. PLoS One. 2014. PMID: 24740421 Free PMC article.
-
In immune defense: redefining the role of the immune system in chronic disease.Dialogues Clin Neurosci. 2017 Mar;19(1):19-26. doi: 10.31887/DCNS.2017.19.1/drubinow. Dialogues Clin Neurosci. 2017. PMID: 28566944 Free PMC article.
-
Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance.J Mol Med (Berl). 2016 Mar;94(3):267-75. doi: 10.1007/s00109-016-1385-4. Epub 2016 Feb 4. J Mol Med (Berl). 2016. PMID: 26847458 Free PMC article. Review.
-
Molecular Assessment of Plasma Concentrations of Selected Adipokines and IL-8 in Horses with Back Pain and Comorbid Asthma-Based on Clinical Cases.Animals (Basel). 2025 Jan 22;15(3):310. doi: 10.3390/ani15030310. Animals (Basel). 2025. PMID: 39943080 Free PMC article.
References
-
- Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047–9054, 2000 - PubMed
-
- Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 85: 3770–3778, 2000 - PubMed
-
- Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191–198, 2005 - PubMed
-
- Batra A, Okur B, Glauben R, Erben U, Ihbe J, Stroh T, Fedke I, Chang HD, Zeitz M, Siegmund B. Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo. Endocrinology 151: 56–62, 2010 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK078188/DK/NIDDK NIH HHS/United States
- DK-043748/DK/NIDDK NIH HHS/United States
- DK-020593/DK/NIDDK NIH HHS/United States
- R01 DK068036/DK/NIDDK NIH HHS/United States
- DK-085495/DK/NIDDK NIH HHS/United States
- U24 DK059637/DK/NIDDK NIH HHS/United States
- DK-068036/DK/NIDDK NIH HHS/United States
- P60 DK020593/DK/NIDDK NIH HHS/United States
- R56 DK068036/DK/NIDDK NIH HHS/United States
- R01 DK085495/DK/NIDDK NIH HHS/United States
- R56 DK043748/DK/NIDDK NIH HHS/United States
- DK-078188/DK/NIDDK NIH HHS/United States
- DK-059637/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials